Does BISOPROLOL Cause Malignant neoplasm progression? 55 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Malignant neoplasm progression have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.2% of all adverse event reports for BISOPROLOL.
55
Reports of Malignant neoplasm progression with BISOPROLOL
0.2%
of all BISOPROLOL reports
22
Deaths
27
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BISOPROLOL?
Of the 55 reports, 22 (40.0%) resulted in death, 27 (49.1%) required hospitalization, and 7 (12.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BISOPROLOL Alternatives Have Lower Malignant neoplasm progression Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB